Healthcare Equipment and Supplies
Company Overview of TearScience, Inc.
TearScience, Inc. develops diagnostic and treatment devices for dry eye cases. It offers LipiView ocular surface interferometers for observing the tear film, capturing images of the tear film, processing pixels, and evaluating them; and Meibomian gland evaluators for evaluating meibomian gland secretions through gland expression for determining if glands are blocked. The company also provides LipiFlow thermal pulsation devices that treat evaporative dry eye patients; and apply heat to the back of the eyelid, and an intermittent gentle pressure to the outer surface to release the obstruction from meibomian glands and allow the natural flow of lipids to resume. TearScience, Inc. markets its pr...
5151 McCrimmon Parkway
Morrisville, NC 27560
Founded in 2005
Key Executives for TearScience, Inc.
Co-Founder and Chief Technical Officer
Senior Vice President of European Region
Chief Commercial Officer and Senior Vice President
Compensation as of Fiscal Year 2014.
TearScience, Inc. Key Developments
TearScience, Inc. Presents at Piper Jaffray 24th Annual Health Care Conference, Nov-28-2012 11:50 AM
Nov 24 12
TearScience, Inc. Presents at Piper Jaffray 24th Annual Health Care Conference, Nov-28-2012 11:50 AM. Venue: The New York Palace, 455 Madison Avenue, New York, NY 10022, United States.
TearScience, Inc. Names Wade Hampton as Senior Vice President and Chief Commercial Officer
Oct 19 12
TearScience, Inc. has appointed Wade Hampton as senior vice president and chief commercial officer. Hampton will focus on the commercialization of TearScience's dry eye treatment system, particularly in North America. Previously, Hampton was a managing partner of Baron Minor Group, an aesthetic, surgical and ophthalmic medical device company. His resume also includes stints at Accuray Inc. and Lumenis Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries